ID: ALA4174100

Max Phase: Preclinical

Molecular Formula: C17H18N2O2S

Molecular Weight: 314.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN1C(=O)C(=C/C=C/c2ccccc2)C(=O)N(CC)C1=S

Standard InChI:  InChI=1S/C17H18N2O2S/c1-3-18-15(20)14(16(21)19(4-2)17(18)22)12-8-11-13-9-6-5-7-10-13/h5-12H,3-4H2,1-2H3/b11-8+

Standard InChI Key:  WARNILUNFMPQTQ-DHZHZOJOSA-N

Associated Targets(Human)

CHL-1 186 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

UACC-903 393 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 314.41Molecular Weight (Monoisotopic): 314.1089AlogP: 2.62#Rotatable Bonds: 4
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.36CX LogD: 3.36
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.49Np Likeness Score: -0.68

References

1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK..  (2018)  Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells.,  143  [PMID:29133035] [10.1016/j.ejmech.2017.11.006]

Source